Chapter 9. Endothelin Antagonists

Annual Reports in Medicinal Chemistry

Volumn 31, Issue C, 1996, Pages 81-90

  Lago, M A ^a   Luengo, J I ^a   Peishoff, C E ^a   Elliott, J D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957106047     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(08)60448-0     Document Type: Article

References (73)

1. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T.A. Nature 332 (1988) 411
2. Spellmeyer D.C. Annu. Rep. Med. Chem. 29 (1994) 65
3. Walsh T.F. Annu. Rep. Med. Chem. 30 (1995) 91
4. Sokolovsky M. Pharmac. Ther. 68 (1995) 435
5. Masaki T. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 435
6. Inagami T., Naruse M., and Hoover R. Annu. Rev. Physiol. 57 (1995) 171
7. Opgenorth T.J. Adv. Pharmacol. 33 (1995) 1
8. Cody W.L., and Doherty A.M. Biopolymers 37 (1995) 89
9. Turner A.J., and Murphy L.J. Biochem. Pharmacol. 51 (1996) 91
10. Ferro C.J., and Webb D.J. Drugs 51 (1996) 12
11. J. Cardiovasc. Pharmacol. 26 Suppl. 3 (1995) S1-S521
12. In: Ruffolo Jr. R.R. (Ed). Endothelin Receptors: From the Gene to the Human (1995), CRC Press, Boca Raton, Fla
13. Denault J.-B., D'Orléans-Juste P., Masaki T., and Leduc R. J. Cardiovasc. Pharmacol. 26 Suppl. 3 (1995) S47
14. Shimada K., Takahashi M., and Tanzawa K. J. Biol. Chem. 269 (1994) 18275
15. Xu D., Emoto N., Giaid A., Slaughter C., Kaw S., deWit D., and Yanagisawa M. Cell. 78 (1994) 473
16. Ikura T., Sawamura T., Shiraki T., Hosokawa H., Kido T., Hoshikawa H., Shimada K., Tanzawa K., Kobayashi S., Miwa S., and Masaki T. Biochem. Biophys. Res. Commun. 207 (1995) 807
17. Schmidt M., Kroger B., Jacob E., Seulberger H., Subkowski T., Otter R., Meyer T., Schmalzing G., and Hillen H. FEBS Letters 356 (1994) 238
18. Yorimitsu K., Moroi K., Inagaki N., Saito T., Masuda Y., Masaki T., Seino S., and Kimura S. Biochem. Biophys. Res. Commun. 208 (1995) 721
19. Shimada K., Matsushita Y., Wakabayashi K., Takahashi M., Matsubara A., lijima Y., and Tanzawa K. Biochem. Biophys. Res. Commun. 207 (1995) 807
20. Emoto N., and Yanagisawa M. J. Biol. Chem. 270 (1995) 15262
21. Valdenaire O., Rohrbacher E., and Mattei M.G. J. Biol. Chem. 270 (1995) 29794
22. Iwasaki S., Homma T., Matsuda Y., and Kon V. J. Biol. Chem. 270 (1995) 6997
23. Kurihara Y., Kurihara H., Suzuki H., Kodama T., Maemura K., Nagai R., Oda H., Kuwai T., Cao W.H., Kamada N., Jishage K., Ouchi Y., Azuma S., Toyoda Y., Ishikawa T., Kumada M., and Yazaki Y. Nature 262 (1994) 703
24. Hosoda K., Giaid A., Hammer R.E., and Yanagisawa M. Circulation 90 (1994) 634
25. Baynash A.G., Hosoda K., Giaid A., Richardson J.A., Emoto N., Hammer R.E., and Yanagisawa M. Cell 79 (1994) 1277
26. Hosoda K., Hammer R.E., Richardson J.A., Baynash A.G., Cheung J.C., Giaid A., and Yanagisawa M. Cell 79 (1994) 1267
27. Puffenberger E.G., Hosoda K., Washington S.S., Nakao K., deWit D., Yanagisawa M., and Chakravarti A. Cell 79 (1994) 1257
28. Tsurumi Y., Ohhata N., Iwamoto T., Shigematsu N., Sakamoto K., Nishikawa M., Kiyoto S., and Okuhara M. J. Antibiot. 47 (1994) 619
29. Bennett T., Gardiner S.M., and Hum J. Hypertens. 8 (1994) 587
30. Tsurumi Y., Fujie K., Nishikawa M., Kiyoto S., and Okuhara M. J. Antibiot. 48 (1995) 169
31. Plumpton C., Haynes W.G., Webb D.J., and Davenport A.P. Br. J. Pharmacol. 116 (1995) 1821
32. Kukkola P.J., Savage P., Sakane Y., Berry J.C., Bilci N.A., Ghai R.D., and Jeng A.Y. J. Cardiovasc. Pharmacol. 26 Suppl. 3 (1995) S65
33. Fukami T., Hayama T., Amano Y., Nakamura Y., Arai Y., Matsuyama K., Yano M., and Ishikawa K. Bioorg. Med. Chem. Lett. 4 (1994) 1257
34. Pollock D.M., Shiosaki K., Sullivan G.M., and Opgenorth T.J. Biochem. Biophys. Res. Commun. 186 (1992) 1146
35. Bertenshaw S.R., Rogers R.S., Stem M.K., Norman B.H., Moore W.M., Jerome G.M., Branson L.M., McDonald J.F., MacMahon E.G., and Palomo M.A. J. Med. Chem. 36 (1993) 173
36. Bertenshaw S.R., Talley J.J., Rogers R.S., Carter J.S., Moore W.M., Branson L.M., and Koboldt C.M. Bioorg. Med. Chem. Lett. 3 (1993) 1953
37. C.P. Lee, P.M. Keller, W.E. DeWolf. E.H. Ohlstein and J.D. Elliott, 210th American Chemical Society National Meeting, Chicago, IL, Aug 1994, Abstract MEDI 40.
38. DeLombaert S., Ghai R.D., Jeng A.Y., Trapani A.J., and Webb R.L. Biochem. Biophys. Res. Commun. 204 (1994) 407
39. DeLombaert S., Blanchard L., Berry C., Ghai R.D., and Trapani A.J. Bioorg. Med. Chem. Lett. 5 (1995) 145
40. Bihovsky R., Levinson B.L., Loewi R.C., Erhardt P.W., and Polokoff M.A. J. Med. Chem. 38 (1995) 2119
41. Tsurumi Y., Ueda H., Hayashi K., Takase S., Nishikawa M., Kiyoto S., and Okuhara M. J. Antibiot. 48 (1995) 1066
42. Warner T.D., Battistini B., Doherty A.M., and Corder R. Biochem. Pharmacol. 48 (1994) 625
43. Doherty A.M. Chemical and Structural Approaches to Rational Drug Design (1995), CRC Press, Boca Raton 85
44. Ihara M., Yamanaka R., Ohwaki K., Ozaki S., Fukami T., Ishikawa K., Towers P., and Yano M. Eur. J. Pharm. 274 (1995) 1
45. Battistini B., and Botting R. Drug News & Perspectives 8 (1995) 365
46. Morishita Y., Chiba S., Tsukuda T., Tanaka T., Ogawa T., Yamasaki M., Yoshida M., Kawamoto I., and Matsuda Y. J. Antibiot. 47 (1994) 269
47. Katahira R., Shibata K., Yamasaki M., Matsuda Y., and Yoshida M. Bioorg. Med. Chem. Lett. 5 (1995) 1595
48. Katahira R., Shibata K., Yamasaki M., Matsuda Y., and Yoshida M. Bioorg. Med. Chem. 3 (1995) 1273
49. He J.X., Cody W.L., Flynn M.A., Welch K.M., Reynolds E.E., and Doherty A.M. Bioorg. Med. Chem. Lett. 5 (1995) 621
50. Clozel M., Breau V., Gray G.A., Kalina B., Loffler B.-M., Burri K., Cassal J.-M., Hirth G., Muller M., Neidhart W., and Ramuz H. J. Pharmacol. Exp. Ther. 270 (1994) 228
51. Kiowski W., Sutsch G., Hunziker P., Muller P., Kim J., Oechslin E., Schmitt R., Jones R., and Bertel O. Lancet 346 (1995) 732
52. Jones C.R. Human Experience with Bosentan (1996), Endothelin Inhibitors: Advances in Therapeutic Application & Development, Coronado, CA Feb 5-7
53. Gellai J.M., Jugus M., Fletcher T., Nambi P., Ohlstein E.H., Elliott J.D., and Brooks D.P. J. Pharmacol. Exp. Ther. 275 (1995) 200
54. Douglas S.A., Louden C., Vickery-Clark L.M., Storer B.L., Hart T., Feuerstein G.Z., Elliott J.D., and Ohlstein E.H. Circ. Res. 75 (1994) 190
55. Elliott J.D., Ezekiel M., Gellai M., Douglas S.A., and Ohlstein E.H. FASEB J. 8 4 (1994) A7
56. Brooks D.P., and DePalma P.D. Nephron 72 (1996) 629
57. M.A. Lago, R.D. Cousins, A. Gao, J.D. Leber, C.E. Peishoff, E.H. Ohlstein and J.D. Elliott, Fourth International Conference on Endothelin, C44 (abstract) (1995).
58. J.D. Elliott. "The Design and Synthesis of Non-Peptide Endothelin Receptor Anatagonist" Endothelin Inhibitors: Advances in Therapeutic Application & Development, Coronado, CA, Feb 5-7, (1996).
59. A. Gao, M.A. Lago, P. Nambi, E.H. Ohlstein and J.D. Elliott, 211th American Chemical Society National Meeting, 141 (abstract), New Orleans March 24-28 (1996).
60. Doherty A.M., Patt W.C., Edmunds J.J., Berryman K.A., Reisdorph B.R., Plummer M.S., Shahripour A., Lee C., Cheng X.-M., Walker D.M., Haleen S.J., Keiser J.A., Flynn M.A., Welch K.M., Hullak H., Taylor D.G., and Reynolds E.E. J. Med. Chem. 38 (1995) 1259
61. R. Bialecki. Endothelin's Pathologic Role in Pulmonary Hypertension. Endothelin Inhibitors: Advances in Therapeutic Application & Development, Coronado, CA, Feb 5-7, (1996).
62. A.M. Doherty. "Non-peptide Endothelin ETA selective and ETA/ETB Receptor Antagonists" Endothelin Inhibitors: Advances in Therapeutic Application & Development, Coronado, CA, Feb 5-7 (1996).
63. Walsh T.F., Fitch K.J., Williams D.L., Murphy K.L., Nolan N.A., Pettibone D.J., Chang R.S.L., O'Malley S.S., Clineschmidt B.V., Veber D.F., and Greenlee W.J. Bioorg. & Med. Chem. Lett. 5 (1995) 1155
64. T.F. Walsh. The Discovery of Potent, Orally Active, "Acylsulfonamide-Based Non-Peptidic ETA/ETB Receptor Antagonists", Endothelin Inhibitors: Advances in Therapeutic Application & Development, Coronado, CA, Feb 5-7 (1996).
65. Stein P.D., Floyd D.M., Bisaha S., Dickey J., Gitotra R.N., Gougoutas J.Z., Kozlowski M., Lee V.G., Liu E.C., Malley M.F., McMullen C., Mitchell C., Moreland S., Murugesan N., Serafino R., Webb M.L., Ahang R., and Hunt J.T. J. Med. Chem. 38 (1995) 1344
66. M.F. Chan, B. Raju, A. Kois, R.S. Castillo, E.J. Verner, C. Wu, Y.V. Venkatachalapathi, I. Okun, E. Hwang, F.D. Stavros and V.N. Balaji, 209th American Chemical Society National Meeting, 167, 168 (abstracts), Anaheim, CA, April 2-6 (1995).
67. M.F. Chan. "The design and Synthesis of Non-Peptide antagonists Selective for Both the ETA and ETB Receptor subtypes" Endothelin Inhibitors: Advances in Therapeutic Application & Development, Coronado, CA, Feb 5-7 (1996).
68. T.A. Brock. "Therapeutic Uses of Selective ETA Receptor Antagonists in Vascular Diseases" Endothelin Inhibitors: Advances in Therapeutic Application & Development, Coronado, CA, Feb 5-7 (1996).
69. Winn M., von Gelden T.W., Opgenorth T.J., Jae H.S., Tasker A.S., Boyd S.A., Kester J.A., Mantei R.A., Bal R., Sorensen B.K., Wu-Wong J.R., Chiou W.J., Dixon D.B., Novosad E.I., Hernandez L., and Marsh K.C. J. Med. Chem. 39 (1996) 1039
70. P.C. Astles, N.V. Harris, M.F. Harper, R. Lewis, C. McCarthy, I. McLay, T.N. Majid, B. Porter, C. Smith and R.J. A. Walsh, 8th SCI-RSC Medicinal Chemistry Symposium, Cambridge, UK 10-13 September (1995).
71. von Geldern T.W., Hutchins C., Kester J.A., Wu-Wong J.R., Chiou W., Dixon D.B., and Opgenorth T.J. J. Med. Chem. 39 (1996) 957
72. von Geldern T.W., Kester J.A., Bal R., Wu-Wong J.R., Chiou W., Dixon D.B., and Opgenorth T.J. J. Med. Chem. 39 (1996) 968
73. von Geldern T.W., Hoffman D., Kester J.A., Nellans H.N., Dayton B.D., Calzadilla S.V., Marsh K.C., Hernandez L., Chiou W., Dixon D.B., Wu-Wong J.R., and Opgenorth T.J. J. Med. Chem. 39 (1996) 982